Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

Summary

A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.

Timeline

Start

2022-08-26

Primary completion

2024-11-18

Completion

2024-11-18

Drugs

Indications